Head-to-Head

ABBVIE INC. vs. Atossa Therapeutics, Inc. Common Stock

ABBV

ABBVIE INC.

$291.31 +1.07%

VS ATOS

Atossa Therapeutics, Inc. Common Stock

$2.02 -4.72%

ABBVIE INC. (ABBV) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABBVATOS
Market Cap $509.50 billion $21.16 million

ABBV leads on 1 of 1 size & scale factors.

Dividend

ABBVATOS
Dividend Yield 2.50% —

ABBV and ATOS split the dividend factors evenly.

Risk & Sentiment

ABBVATOS
Short Interest 0.85% 15.54%

ABBV leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABBV overview, ABBV financials, ATOS overview, ATOS financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.